Epigenetics of Alzheimer's and Parkinson's Disease Part A

Epigenetics of Alzheimer's and Parkinson's Disease Part A, published as Volume 118 of the serial Advances in Genetics, provides a focused survey of the epigenetic mechanisms underlying two of the most prevalent neurodegenerative disorders. Contributions from international researchers examine microRNA-based therapeutic strategies, exosome-mediated pathways, noncoding RNA regulation, DNA and histone modifications, and gene-environment-epigenome interactions in Alzheimer's and Parkinson's disease. The volume offers researchers a current reference point for understanding how epigenetic regulation contributes to disease onset and progression, and how these mechanisms might be targeted therapeutically.

• Surveys epigenetic mechanisms - miRNA, noncoding RNA, DNA/histone modification - implicated in Alzheimer's and Parkinson's disease
• Covers exosome-mediated pathways and gene-environment-epigenome interactions in neurodegeneration
• Authored by international contributors across genetics, molecular biology, and neuroscience
• Provides a reference point for both mechanistic understanding and emerging epigenetic-targeted therapeutic strategies
• Part of the long-running Advances in Genetics serial, maintaining continuity with established editorial standards